ArticleJournal of fungi (Basel, Switzerland)2022
Antifungal Activity of Copper Oxide Nanoparticles against Root Rot Disease in Cucumber.
Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 77 citations in OpenAlex.
- Myco-synthesized copper oxide nanoparticles as a sustainable bionanofungicide for managing Fusarium falciforme and enhancing potato productivity.Scientific reports · 2026Article
- Nanoparticle-Induced Cross-Tolerance: A Review of Mechanisms for Concurrent Biotic and Abiotic Stress Mitigation in Crops.Plants (Basel, Switzerland) · 2026Review
- MgO and Zn/MgO Nanoparticles as Direct Antifungal Compounds and Elicitors AgainstJournal of fungi (Basel, Switzerland) · 2026Article
- TheGenes · 2026Article
- Enhancing apple disease resistance via magnetic nanoparticle-mediated delivery of artificial miRNAs that suppress a tRNA-derived small RNA targeting a disease-resistant gene.Plant communications · 2026Article
- Applications of nanoparticles in plant disease identification and control for sustainable crop production.Discover nano · 2026Review
- Innovative Application of Nanomaterials in Vegetable Cultivation: Recent Advances in Growth Promotion and Stress Tolerance.Nanomaterials (Basel, Switzerland) · 2025Review
- Metal-Based Nanoparticles with Biostimulatory Effects: Harnessing Nanotechnology for Enhanced Agricultural Sustainability.Materials (Basel, Switzerland) · 2025Review
- Coating Seeds withBiology · 2025Article
- Toxicity of copper oxide nanoparticles in barley: induction of oxidative stress, hormonal imbalance, and systemic resistances.BMC plant biology · 2025Article
- One-Pot Synthesis and Characterization of Magnetic α-FeChemistryOpen · 2025Article
- Article
- Article
- Eco-friendly green synthesis of silver nanoparticles from guajava leaves extract for controlling organophosphorus pesticides hazards, characterization, and in-vivo toxicity assessment.BMC pharmacology & toxicology · 2024Article
- Green Synthesis, Characterization and Pharmaceutical Applications of Biocompatible Zinc Oxide Nanoparticles UsingPharmaceuticals (Basel, Switzerland) · 2024Article
- Antibacterial Properties of Copper Oxide Nanoparticles (Review).International journal of molecular sciences · 2024Review
- Metal oxide nanoparticles as a promising method to reduce biotic stress in plant cell wall: A review.Heliyon · 2024Review
- Nanomaterials for Plant Disease Diagnosis and Treatment: A Review.Plants (Basel, Switzerland) · 2024Review
- Aflatoxins in Peanut (ACS omega · 2024Review
- Nanoparticles as a Tool for Alleviating Plant Stress: Mechanisms, Implications, and Challenges.Plants (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 3 countries.
Funding
Abstract
Metal oxide nanoparticles have recently garnered interest as potentially valuable substances for the management of plant diseases. Copper oxide nanoparticles (Cu
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.